Skip to content

Ba-Bao-Dan in the adjuvant therapy of novel coronavirus pneumonia (COVID-19) patients

Study for the pharmacodynamics and mechanism of traditional Chinese medicine in the treatment of novel coronavirus infection (COVID-19) based on inflammatory factor network

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029819
Enrollment
Unknown
Registered
2020-02-14
Start date
2020-02-11
Completion date
Unknown
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Experimental group:Conventional treatment + take Ba-Bao-Dan
Control group:Conventional treatment

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years, unlimited for men and women; 2. A novel coronavirus infection confirmed by pathogenic detection; 3. According to novel coronavirus infection pneumonia treatment plan (trial version fifth), severe patients should comply with any of the following: respiratory distress (RR>30 times / points); resting state, refers to oxygen saturation less than 93%; arterial oxygen partial pressure (PaO2) / oxygen inhalation concentration (FiO2) is less than 300 mmHg; 4. Sign the informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. The patients had mental disorder, drug abuse or dependence history, allergy to research drugs, and participated in other clinical studies within 3 months; 3. Potential violation of test compliance or any other situation affecting safety and effectiveness evaluation.

Design outcomes

Primary

MeasureTime frame
Clinical and laboratory indicators;Viral load;chest CT;serum cell factor;

Countries

China

Contacts

Public ContactYing Kejing

Sir Run Run Show Hospital, School of Medicine, Zhejiang University

yingsrrsh@163.com+86 13588706900

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026